New class of non-β-lactam antibiotics to treat methicillin-resistant Staphylococcus aureus (MRSA)
Posted March 25, 2014 by lorrainegenscript
A team of scientists have discovered a new class of antibiotics with 100% oral bioavailability to fight drug-resistant bacteria including MRSA
Feature News
This new class, called oxadiazoles, was discovered in silico screening and inhibits penicillin-binding protein 2a (PBP2a) and the biosynthesis of the cell wall which enable MRSA to resist other drugs.
What are the public health implications?
-- END ---
Share
| Contact Email | [email protected] |
| Issued By | lorraine xu |
| Country | United States |
| Categories | Health |
| Tags | genscript us ainc |
| Last Updated | March 25, 2014 |